FIELD: medicine, immunology.
SUBSTANCE: one should detect the content of serumal TNF-α, IL-6, IL-12 both before and after introducing remicade preparation at the dosage of 4-6 mg/kg and at a twofold decreased content of serumal TNFα and IL-6 by 37% and more and at increased level of IL-12 by 230-250% one should consider immunological correction of Crohn's disease and inspecific ulcerous colitis to be necessary.
EFFECT: higher accuracy of detection.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2463055C2 |
THERAPY OF INFLAMMATORY BOWEL DISEASES | 2008 |
|
RU2364405C1 |
METHOD FOR PREDICTING GASTRIC AND DUODENAL PEPTIC ULCER CASES | 2003 |
|
RU2241228C1 |
METHOD OF EVALUATING EFFICIENCY OF CROHN'S DISEASE AND ULCERATIVE COLITIS TREATMENT | 2008 |
|
RU2391914C2 |
METHOD OF ASSESSING CLINICAL EFFECTIVENESS IN INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2477478C1 |
METHOD OF ULCERATIVE COLITIS AND CROHN'S DISEASE THERAPY | 2011 |
|
RU2460554C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DISTINGUISHING CHRONIC PANCREATITIS CASES OF ALCOHOLIC AND BILIARY ETIOLOGY | 2005 |
|
RU2302003C1 |
DIAGNOSTIC TECHNIQUE FOR BRONCHIAL OBSTRUCTION ACCOMPANYING INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2451488C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF STOMACH- OR DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI | 2003 |
|
RU2269132C2 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING RECURRENT INFLAMMATORY INTESTINAL DISEASES | 2012 |
|
RU2517069C1 |
Authors
Dates
2005-08-10—Published
2003-10-31—Filed